DataLibraryResearch is tracking the market dynamics of the crisis in the Pharma & Healthcare industry amid lock-down changes in the supply chain.

Get detailed analysis of the COVID-19 impact on the Orthobiologics Market

Global Orthobiologics Market Opportunities and Forecast 2020-2027

  • DLR2475
  • 02 August, 2021
  • Pharma & Healthcare
  • Pages: 120
  • Global
Global Orthobiologics Market, By Product (Bone Morphogenetic Proteins, Demineralized Bone Matrix, Synthetic Bone Substitutes, Viscosupplements, Allografts, Stem Cells, Others), By Application (Spinal Fusion, Trauma Repair, Reconstructive Surgeries, Others), By End-User (Hospitals, Orthopedic Clinics, Others), and opportunities and forecast 2020-2027.

Orthobiologics Market Overview

Orthobiologics are substances that orthopaedic surgeons use to help injuries heal more quickly. They are used to improve the healing of broken bones and injured muscles, tendons, and ligaments. These products are often made from substances that are naturally found in your body. When they are used in higher concentrations, they may help speed up the healing process. The global Orthobiologics market is expected to enlarge at a significant rate in the forecast period due to increased acceptance of these substances globally.

Presently, there is huge growth in orthopedic injuries including injuries due to road accidents and sports injuries. This key fact is expected to create various opportunities for vendors operating in the global orthobiologics market. As well, increasing cases of spinal fusion surgeries and the growing old age population across the world are projected to fuel the growth of the global orthobiologics market. As per data of Spinal Cord, Inc., the U.S. had 245,000 to 353,000 people living with spinal cord injury in 2017. Furthermore, other factors such as increased obesity problems globally and rising musculoskeletal disorders majorly contribute to the growth of the orthobiologics market. Besides this, growth in inclination towards minimally invasive procedures further rises the opportunities for the global orthobiologics market.

On the other hand, less reimbursement and stringent regulatory requirements may hamper the growth of the orthobiologics market in the forecast period.

Covid-19 Impact on Orthobiologics Market:

In addition, the current Orthobiologics Market study offers a detailed analysis of the current COVID-19 pandemic impact on the market growth and its influence on the future growth of the Orthobiologics Market. The recently published report demonstrates the elevation in the demand for the healthcare sector. The healthcare manufacturers have experienced long term as well as short term effect which includes supply shortages, panic buying, and stocking, regulation changes as short-term whereas approval delays and possible trend variations in consumption could be perceived as long-term impacts of COVID-19 on the health and pharmaceutical market.

The increasing need for a cure has pushed vaccine research and manufacturers to the limit. In addition to this, panic conditions have already spurred the demand for many healthcare products and services which are discussed in detail in this report. Moreover, the impact of COVID-19 on overall market revenue for the base year 2020 and its projection up to 2027 is provided in detail in this report.

Orthobiologics Market Segment Overview

Based on product, the Viscosupplementation segment has the largest share of the orthobiologics market. This is due to the rise in the prevalence of knee osteoarthritis. Also, the better reimbursement scenario for the products as these is approved by the U.S. FDA further rises the growth of this segment. In addition to this, France has a well-defined reimbursement policy for viscosupplementation products. Moreover, by application, the spinal fusion segment has significant growth in the market. This is mainly due to the rising prevalence of spine and traumatic injuries, sports-related injuries, and accidents. 

Orthobiologics Market, By Product

·       Bone Morphogenetic Proteins
·       Demineralized Bone Matrix
·       Synthetic Bone Substitutes
·       Viscosupplements
·       Allografts
·       Stem Cells
·       Others

Orthobiologics Market, By Application

·       Spinal Fusion
·       Trauma Repair
·       Reconstructive Surgeries
·       Others

Orthobiologics Market, By End-User

·       Hospitals
·       Orthopedic Clinics
·       Others

Orthobiologics Regional Overview

Region-wise, North America accounted for the maximum share of the global orthobiologics market. Factors such as rapid development in the technologies in orthobiologics, growing sports-related injuries, and injuries due to accidents have fueled the growth of the market in this region. Similarly, the Asia Pacific region is expected to have a major share of orthobiologics market. This is due to the increase in orthopedic procedures and surge in the old age population in China and India. Moreover, the market in the Middle East & Africa is projected to rise at a considerable rate due to the increasing old age population in this region.

Orthobiologics Market, By Geography

·       North America (US & Canada)
·       Europe (UK, Germany, France, Italy, Spain, Russia & Rest of Europe)
·       Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
·       LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)

Orthobiologics Market Competitor overview

Some key developments and strategies adopted by manufacturers in Orthobiologics are highlighted below.

·       In July 2021, Recently listed Bioventus Inc has agreed to acquire Misonix Inc for $518 million in a cash-and-stock transaction. Misonix stockholders may elect to receive either 1.6839 Bioventus shares or $28.00 in cash in the transaction.

·       In September 2018, NuVasive, Inc.the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, announced the U.S. commercial launch of three new biologics offerings to include traditional bone allograft, amniotic membrane DS and additional form factors to the current PropelTM DBM product line. This portfolio expansion demonstrates the Company’s strategic efforts to deliver the most differentiated biologics portfolio in the spine industry.

·       In March 2018, Synergy Biomedical, LLC, a developer of orthobiologic and biomaterial products, announced that it has received Therapeutic Goods Administration (TGA) clearance in Australia for its bioactive bone graft, BIOSPHERE PUTTY. BIOSPHERE PUTTY is an advanced synthetic bone graft product that has previously received FDA and CE Mark clearances, and has been on the market since 2013.

Orthobiologics Market, Key Players

·       Medtronic
·       DePuy Synthes (Johnson & Johnson)
·       Sanofi
·       Seikagaku Corporation
·       Stryker
·       MTF Biologics
·       Bioventus LLC
·       Arthrex
·       Zimmer Biomet
·       RTI Surgical, Inc.
·       Alphatec Spine, Inc.
·       Exactech, Inc.
·       Globus Medical, Inc.
·       Integra LifeSciences

Orthobiologics Market Study Global Market Analysis, Insights and Forecast, 2020-2027

    1. Introduction

    • 1.1. Research Scope
    • 1.2. Market Segmentation
    • 1.3. Research Methodology
    • 1.4. Definitions and Assumptions

    2. Executive Summary

      3. Market Dynamics

      • 3.1. Market Drivers
      • 3.2. Market Restraints
      • 3.3. Market Opportunities

      4. Key Insights

      • 4.1. Key Emerging Trends – For Major Countries
      • 4.2. Latest Technological Advancement
      • 4.3. Regulatory Landscape
      • 4.4. Industry SWOT Analysis
      • 4.5. Porters Five Forces Analysis

      5. Global Orthobiologics Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 5.1. Key Findings / Summary
      • 5.2. Market Analysis, Insights and Forecast – By Product
        • 5.2.1. Bone Morphogenetic Proteins
        • 5.2.2. Demineralized Bone Matrix
        • 5.2.3. Synthetic Bone Substitutes
        • 5.2.4. Viscosupplements
        • 5.2.5. Allografts
        • 5.2.6. Stem Cells
        • 5.2.7. Others
      • 5.3. Market Analysis, Insights and Forecast – By Application
        • 5.3.1. Spinal Fusion
        • 5.3.2. Trauma Repair
        • 5.3.3. Reconstructive Surgeries
        • 5.3.4. Others
      • 5.4. Market Analysis, Insights and Forecast – By End-User
        • 5.4.1. Hospitals
        • 5.4.2. Orthopedic Clinics
        • 5.4.3. Others
      • 5.5. Market Analysis, Insights and Forecast – By Region
        • 5.5.1. North America
        • 5.5.2. Europe
        • 5.5.3. Asia Pacific
        • 5.5.4. Latin America, Middle East and Africa

      6. North America Orthobiologics Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 6.1. Key Findings / Summary
      • 6.2. Market Analysis, Insights and Forecast – By Product
        • 6.2.1. Bone Morphogenetic Proteins
        • 6.2.2. Demineralized Bone Matrix
        • 6.2.3. Synthetic Bone Substitutes
        • 6.2.4. Viscosupplements
        • 6.2.5. Allografts
        • 6.2.6. Stem Cells
        • 6.2.7. Others
      • 6.3. Market Analysis, Insights and Forecast – By Application
        • 6.3.1. Spinal Fusion
        • 6.3.2. Trauma Repair
        • 6.3.3. Reconstructive Surgeries
        • 6.3.4. Others
      • 6.4. Market Analysis, Insights and Forecast – By End-User
        • 6.4.1. Hospitals
        • 6.4.2. Orthopedic Clinics
        • 6.4.3. Others
      • 6.5. Market Analysis, Insights and Forecast – By Country
        • 6.5.1. U.S.
        • 6.5.2. Canada

      7. Europe Orthobiologics Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 7.1. Key Findings / Summary
      • 7.2. Market Analysis, Insights and Forecast – By Product
        • 7.2.1. Bone Morphogenetic Proteins
        • 7.2.2. Demineralized Bone Matrix
        • 7.2.3. Synthetic Bone Substitutes
        • 7.2.4. Viscosupplements
        • 7.2.5. Allografts
        • 7.2.6. Stem Cells
        • 7.2.7. Others
      • 7.3. Market Analysis, Insights and Forecast – By Application
        • 7.3.1. Spinal Fusion
        • 7.3.2. Trauma Repair
        • 7.3.3. Reconstructive Surgeries
        • 7.3.4. Others
      • 7.4. Market Analysis, Insights and Forecast – By End-User
        • 7.4.1. Hospitals
        • 7.4.2. Orthopedic Clinics
        • 7.4.3. Others
      • 7.5. Market Analysis, Insights and Forecast – By Country
        • 7.5.1. UK
        • 7.5.2. Germany
        • 7.5.3. France
        • 7.5.4. Italy
        • 7.5.5. Spain
        • 7.5.6. Russia
        • 7.5.7. Rest of Europe

      8. Asia Pacific Orthobiologics Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 8.1. Key Findings / Summary
      • 8.2. Market Analysis, Insights and Forecast – By Product
        • 8.2.1. Bone Morphogenetic Proteins
        • 8.2.2. Demineralized Bone Matrix
        • 8.2.3. Synthetic Bone Substitutes
        • 8.2.4. Viscosupplements
        • 8.2.5. Allografts
        • 8.2.6. Stem Cells
        • 8.2.7. Others
      • 8.3. Market Analysis, Insights and Forecast – By Application
        • 8.3.1. Spinal Fusion
        • 8.3.2. Trauma Repair
        • 8.3.3. Reconstructive Surgeries
        • 8.3.4. Others
      • 8.4. Market Analysis, Insights and Forecast – By End-User
        • 8.4.1. Hospitals
        • 8.4.2. Orthopedic Clinics
        • 8.4.3. Others
      • 8.5. Market Analysis, Insights and Forecast – By Country
        • 8.5.1. China
        • 8.5.2. India
        • 8.5.3. Japan
        • 8.5.4. Australia
        • 8.5.5. South East Asia
        • 8.5.6. Rest of Asia Pacific

      9. Latin America, Middle East and Africa Orthobiologics Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 9.1. Key Findings / Summary
      • 9.2. Market Analysis, Insights and Forecast – By Product
        • 9.2.1. Bone Morphogenetic Proteins
        • 9.2.2. Demineralized Bone Matrix
        • 9.2.3. Synthetic Bone Substitutes
        • 9.2.4. Viscosupplements
        • 9.2.5. Allografts
        • 9.2.6. Stem Cells
        • 9.2.7. Others
      • 9.3. Market Analysis, Insights and Forecast – By Application
        • 9.3.1. Spinal Fusion
        • 9.3.2. Trauma Repair
        • 9.3.3. Reconstructive Surgeries
        • 9.3.4. Others
      • 9.4. Market Analysis, Insights and Forecast – By End-User
        • 9.4.1. Hospitals
        • 9.4.2. Orthopedic Clinics
        • 9.4.3. Others
      • 9.5. Market Analysis, Insights and Forecast – By Country
        • 9.5.1. Brazil
        • 9.5.2. Saudi Arabia
        • 9.5.3. UAE
        • 9.5.4. Rest of LAMEA

      10. Competitive Analysis

      • 10.1. Company Market Share Analysis, 2018
      • 10.2. Key Industry Developments
      • 10.3. Company Profile
      • 10.4. Medtronic
        • 10.4.1. Business Overview
        • 10.4.2. Segment 1 & Service Offering
        • 10.4.3. Overall Revenue
        • 10.4.4. Geographic Presence
        • 10.4.5. Recent Development
      *Similar details will be provided for the following companies
      • 10.5. DePuy Synthes (Johnson & Johnson)
      • 10.6. Sanofi
      • 10.7. Seikagaku Corporation
      • 10.8. Stryker
      • 10.9. MTF Biologics
      • 10.10. Bioventus LLC
      • 10.11. Arthrex
      • 10.12. Zimmer Biomet
      • 10.13. RTI Surgical, Inc.
      • 10.14. Alphatec Spine, Inc.
      • 10.15. Exactech, Inc.
      • 10.16. Globus Medical, Inc.
      List of Figures

      Figure 1: Global Orthobiologics Market Revenue Breakdown (USD Billion, %) by Region, 2019 & 2027
      Figure 2: Global Orthobiologics Market Value Share (%), By Segment 1, 2019 & 2027
      Figure 3: Global Orthobiologics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 4: Global Orthobiologics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 5: Global Orthobiologics Market Value Share (%), By Segment 2, 2019 & 2027
      Figure 6: Global Orthobiologics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 7: Global Orthobiologics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 8: Global Orthobiologics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 9: Global Orthobiologics Market Forecast (USD Billion), by Others, 2016-2027
      Figure 10: Global Orthobiologics Market Value Share (%), By Segment 3, 2019 & 2027
      Figure 11: Global Orthobiologics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 12: Global Orthobiologics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 13: Global Orthobiologics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 14: Global Orthobiologics Market Forecast (USD Billion), by Others, 2016-2027
      Figure 15: Global Orthobiologics Market Value (USD Billion), by Region, 2019 & 2027
      Figure 16: North America Orthobiologics Market Value Share (%), By Segment 1, 2019 & 2027
      Figure 17: North America Orthobiologics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 18: North America Orthobiologics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 19: North America Orthobiologics Market Value Share (%), By Segment 2, 2019 & 2027
      Figure 20: North America Orthobiologics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 21: North America Orthobiologics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 22: North America Orthobiologics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 23: North America Orthobiologics Market Forecast (USD Billion), by Others, 2016-2027
      Figure 24: North America Orthobiologics Market Value Share (%), By Segment 3, 2019 & 2027
      Figure 25: North America Orthobiologics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 26: North America Orthobiologics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 27: North America Orthobiologics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 28: North America Orthobiologics Market Forecast (USD Billion), by Others, 2016-2027
      Figure 29: North America Orthobiologics Market Forecast (USD Billion), by U.S., 2016-2027
      Figure 30: North America Orthobiologics Market Forecast (USD Billion), by Canada, 2016-2027
      Figure 31: Latin America Orthobiologics Market Value Share (%), By Segment 1, 2019 & 2027
      Figure 32: Latin America Orthobiologics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 33: Latin America Orthobiologics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 34: Latin America Orthobiologics Market Value Share (%), By Segment 2, 2019 & 2027
      Figure 35: Latin America Orthobiologics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 36: Latin America Orthobiologics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 37: Latin America Orthobiologics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 38: Latin America Orthobiologics Market Forecast (USD Billion), by Others, 2016-2027
      Figure 39: Latin America Orthobiologics Market Value Share (%), By Segment 3, 2019 & 2027
      Figure 40: Latin America Orthobiologics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 41: Latin America Orthobiologics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 42: Latin America Orthobiologics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 43: Latin America Orthobiologics Market Forecast (USD Billion), by Others, 2016-2027
      Figure 44: Latin America Orthobiologics Market Forecast (USD Billion), by Brazil, 2016-2027
      Figure 45: Latin America Orthobiologics Market Forecast (USD Billion), by Mexico, 2016-2027
      Figure 46: Latin America Orthobiologics Market Forecast (USD Billion), by Rest of Latin America, 2016-2027
      Figure 47: Europe Orthobiologics Market Value Share (%), By Segment 1, 2019 & 2027
      Figure 48: Europe Orthobiologics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 49: Europe Orthobiologics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 50: Europe Orthobiologics Market Value Share (%), By Segment 2, 2019 & 2027
      Figure 51: Europe Orthobiologics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 52: Europe Orthobiologics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 53: Europe Orthobiologics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 54: Europe Orthobiologics Market Forecast (USD Billion), by Others, 2016-2027
      Figure 55: Europe Orthobiologics Market Value Share (%), By Segment 3, 2019 & 2027
      Figure 56: Europe Orthobiologics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 57: Europe Orthobiologics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 58: Europe Orthobiologics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 59: Europe Orthobiologics Market Forecast (USD Billion), by Others, 2016-2027
      Figure 60: Europe Orthobiologics Market Forecast (USD Billion), by U.K., 2016-2027
      Figure 61: Europe Orthobiologics Market Forecast (USD Billion), by Germany, 2016-2027
      Figure 62: Europe Orthobiologics Market Forecast (USD Billion), by France, 2016-2027
      Figure 63: Europe Orthobiologics Market Forecast (USD Billion), by Italy, 2016-2027
      Figure 64: Europe Orthobiologics Market Forecast (USD Billion), by Spain, 2016-2027
      Figure 65: Europe Orthobiologics Market Forecast (USD Billion), by Russia, 2016-2027
      Figure 66: Europe Orthobiologics Market Forecast (USD Billion), by Rest of Europe, 2016-2027
      Figure 67: Asia Pacific Orthobiologics Market Value Share (%), By Segment 1, 2019 & 2027
      Figure 68: Asia Pacific Orthobiologics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 69: Asia Pacific Orthobiologics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 70: Asia Pacific Orthobiologics Market Value Share (%), By Segment 2, 2019 & 2027
      Figure 71: Asia Pacific Orthobiologics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 72: Asia Pacific Orthobiologics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 73: Asia Pacific Orthobiologics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 74: Asia Pacific Orthobiologics Market Forecast (USD Billion), by Others, 2016-2027
      Figure 75: Asia Pacific Orthobiologics Market Value Share (%), By Segment 3, 2019 & 2027
      Figure 76: Asia Pacific Orthobiologics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 77: Asia Pacific Orthobiologics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 78: Asia Pacific Orthobiologics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 79: Asia Pacific Orthobiologics Market Forecast (USD Billion), by Others, 2016-2027
      Figure 80: Asia Pacific Orthobiologics Market Forecast (USD Billion), by China, 2016-2027
      Figure 81: Asia Pacific Orthobiologics Market Forecast (USD Billion), by India, 2016-2027
      Figure 82: Asia Pacific Orthobiologics Market Forecast (USD Billion), by Japan, 2016-2027
      Figure 83: Asia Pacific Orthobiologics Market Forecast (USD Billion), by Australia, 2016-2027
      Figure 84: Asia Pacific Orthobiologics Market Forecast (USD Billion), by Southeast Asia, 2016-2027
      Figure 85: Asia Pacific Orthobiologics Market Forecast (USD Billion), by Rest of Asia Pacific, 2016-2027
      Figure 86: Middle East & Africa Orthobiologics Market Value Share (%), By Segment 1, 2019 & 2027
      Figure 87: Middle East & Africa Orthobiologics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 88: Middle East & Africa Orthobiologics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 89: Middle East & Africa Orthobiologics Market Value Share (%), By Segment 2, 2019 & 2027
      Figure 90: Middle East & Africa Orthobiologics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 91: Middle East & Africa Orthobiologics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 92: Middle East & Africa Orthobiologics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 93: Middle East & Africa Orthobiologics Market Forecast (USD Billion), by Others, 2016-2027
      Figure 94: Middle East & Africa Orthobiologics Market Value Share (%), By Segment 3, 2019 & 2027
      Figure 95: Middle East & Africa Orthobiologics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 96: Middle East & Africa Orthobiologics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 97: Middle East & Africa Orthobiologics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 98: Middle East & Africa Orthobiologics Market Forecast (USD Billion), by Others, 2016-2027
      Figure 99: Middle East & Africa Orthobiologics Market Forecast (USD Billion), by GCC, 2016-2027
      Figure 100: Middle East & Africa Orthobiologics Market Forecast (USD Billion), by South Africa, 2016-2027
      Figure 101: Middle East & Africa Orthobiologics Market Forecast (USD Billion), by Rest of Middle East & Africa, 2016-2027 
      List of Tables
      Table 1: Global Orthobiologics Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
      Table 2: Global Orthobiologics Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
      Table 3: Global Orthobiologics Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
      Table 4: Global Orthobiologics Market Revenue (USD Billion) Forecast, by Region, 2016-2027
      Table 5: North America Orthobiologics Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
      Table 6: North America Orthobiologics Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
      Table 7: North America Orthobiologics Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
      Table 8: North America Orthobiologics Market Revenue (USD Billion) Forecast, by Country, 2016-2027
      Table 9: Europe Orthobiologics Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
      Table 10: Europe Orthobiologics Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
      Table 11: Europe Orthobiologics Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
      Table 12: Europe Orthobiologics Market Revenue (USD Billion) Forecast, by Country, 2016-2027
      Table 13: Latin America Orthobiologics Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
      Table 14: Latin America Orthobiologics Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
      Table 15: Latin America Orthobiologics Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
      Table 16: Latin America Orthobiologics Market Revenue (USD Billion) Forecast, by Country, 2016-2027
      Table 17: Asia Pacific Orthobiologics Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
      Table 18: Asia Pacific Orthobiologics Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
      Table 19: Asia Pacific Orthobiologics Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
      Table 20: Asia Pacific Orthobiologics Market Revenue (USD Billion) Forecast, by Country, 2016-2027
      Table 21: Middle East & Africa Orthobiologics Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
      Table 22: Middle East & Africa Orthobiologics Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
      Table 23: Middle East & Africa Orthobiologics Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
      Table 24: Middle East & Africa Orthobiologics Market Revenue (USD Billion) Forecast, by Country, 2016-2027

      Report You Might be Interested

      Choose License Type

      • USD
      • GBP
      • EURO
      • INR
      Credit card Logo

      Happy To Assist You

      Have a Question? email us at

      info@datalibraryresearch.com

      Or Call Us On

      US +1 360 851 1343

      IND +91 880 579 4934